Etalocib

• Target:

  LTR|||Apoptosis|||Leukotriene Receptor

• Related Pathways:

  Immunology/Inflammation|||GPCR/G Protein|||Apoptosis

• Purity:

  0.9892

• Bioactivity:

  Etalocib (LY293111) is a novel diaryl ether carboxylic acid derivative, is a selective and potent inhibitor of the lipoxygenase pathway either via antagonism of the leukotriene B4 (LTB4) receptor or directly through 5'-lipoxygenase. It has antineoplastic activities.

• Smiles:

  CCCc1c(OCCCOc2cc(O)c(cc2CC)-c2ccc(F)cc2)cccc1Oc1ccccc1C(O)=O

• Molecular Formula:

  C33H33FO6

• Molecular Weight:

  544.6

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  161172-51-6